Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
BMC Cardiovasc Disord ; 9: 32, 2009 Jul 26.
Article in English | MEDLINE | ID: mdl-19631001

ABSTRACT

BACKGROUND: The impact of reducing door-to-balloon time on hospital revenues, costs, and net income is unknown. METHODS: We prospectively determined the impact on hospital finances of (1) emergency department physician activation of the catheterization lab and (2) immediate transfer of the patient to an immediately available catheterization lab by an in-house transfer team consisting of an emergency department nurse, a critical care unit nurse, and a chest pain unit nurse. We collected financial data for 52 consecutive ST-elevation myocardial infarction patients undergoing emergency percutaneous intervention from October 1, 2004-August 31, 2005 and compared this group to 80 consecutive ST-elevation myocardial infarction patients from September 1, 2005-June 26, 2006 after protocol implementation. RESULTS: Per hospital admission, insurance payments (hospital revenue) decreased ($35,043 +/- $36,670 vs. $25,329 +/- $16,185, P = 0.039) along with total hospital costs ($28,082 +/- $31,453 vs. $18,195 +/- $9,242, P = 0.009). Hospital net income per admission was unchanged ($6962 vs. $7134, P = 0.95) as the drop in hospital revenue equaled the drop in costs. For every $1000 reduction in total hospital costs, insurance payments (hospital revenue) dropped $1077 for private payers and $1199 for Medicare/Medicaid. A decrease in hospital charges ($70,430 +/- $74,033 vs. $53,514 +/- $23,378, P = 0.059), diagnosis related group relative weight (3.7479 +/- 2.6731 vs. 2.9729 +/- 0.8545, P = 0.017) and outlier payments with hospital revenue>$100,000 (7.7% vs. 0%, P = 0.022) all contributed to decreasing ST-elevation myocardial infarction hospitalization revenue. One-year post-discharge financial follow-up revealed similar results: Insurance payments: $49,959 +/- $53,741 vs. $35,937 +/- $23,125, P = 0.044; Total hospital costs: $39,974 +/- $37,434 vs. $26,778 +/- $15,561, P = 0.007; Net Income: $9984 vs. $9159, P = 0.855. CONCLUSION: All of the financial benefits of reducing door-to-balloon time in ST-elevation myocardial infarction go to payers both during initial hospitalization and after one-year follow-up. TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT00800163.


Subject(s)
Angioplasty, Balloon, Coronary/economics , Emergency Service, Hospital/economics , Hospital Charges , Hospital Costs , Myocardial Infarction/economics , Myocardial Infarction/therapy , Patient Care Team/economics , Patient Transfer/economics , Quality of Health Care/economics , Cost-Benefit Analysis , Humans , Insurance, Health, Reimbursement , Length of Stay/economics , Medicaid/economics , Medicare/economics , Patient Admission/economics , Prospective Studies , Time Factors , Treatment Outcome , United States
2.
Circulation ; 116(1): 67-76, 2007 Jul 03.
Article in English | MEDLINE | ID: mdl-17562960

ABSTRACT

BACKGROUND: Consensus guidelines and hospital quality-of-care programs recommend that ST-elevation myocardial infarction patients achieve a door-to-balloon time of < or = 90 minutes. However, there are limited prospective data on specific measures to significantly reduce door-to-balloon time. METHODS AND RESULTS: We prospectively determined the impact on median door-to-balloon time of a protocol mandating (1) emergency department physician activation of the catheterization laboratory and (2) immediate transfer of the patient to an immediately available catheterization laboratory by an in-house transfer team consisting of an emergency department nurse, a critical care unit nurse, and a chest pain unit nurse. We collected door-to-balloon time for 60 consecutive ST-elevation myocardial infarction patients undergoing emergency percutaneous intervention within 24 hours of presentation from October 1, 2004, through August 31, 2005, and compared this group with 86 consecutive ST-elevation myocardial infarction patients from September 1, 2005, through June 26, 2006, after protocol implementation. Median door-to-balloon time decreased overall (113.5 versus 75.5 minutes; P<0.0001), during regular hours (83.5 versus 64.5 minutes; P=0.005), during off-hours (123.5 versus 77.5 minutes; P<0.0001), and with transfer from an outside affiliated emergency department (147 versus 85 minutes; P=0.0006). Treatment within 90 minutes increased from 28% to 71% (P<0.0001). Mean infarct size decreased (peak creatinine kinase, 2623+/-3329 versus 1517+/-1556 IU/L; P=0.0089), as did hospital length of stay (5+/-7 versus 3+/-2 days; P=0.0097) and total hospital costs per admission ($26,826+/-29,497 versus $18,280+/-8943; P=0.0125). CONCLUSIONS: Emergency department physician activation of the catheterization laboratory and immediate transfer of the patient to an immediately available catheterization laboratory reduce door-to-balloon time, leading to a reduction in myocardial infarct size, hospital length of stay, and total hospital costs.


Subject(s)
Angioplasty, Balloon, Coronary , Cardiac Catheterization , Disease Management , Emergency Service, Hospital/organization & administration , Hospital Communication Systems/organization & administration , Myocardial Infarction/therapy , Patient Care Team , Patient Transfer , Adult , Aged , Angioplasty, Balloon, Coronary/economics , Angioplasty, Balloon, Coronary/statistics & numerical data , Early Diagnosis , Emergency Medical Services/organization & administration , Emergency Nursing , Female , First Aid , Follow-Up Studies , Guideline Adherence , Hospital Costs , Hospital Mortality , Hospitals, Community/statistics & numerical data , Humans , Indiana/epidemiology , Interdisciplinary Communication , Length of Stay/statistics & numerical data , Male , Middle Aged , Myocardial Infarction/diagnosis , Myocardial Infarction/economics , Myocardial Infarction/mortality , Myocardial Infarction/nursing , Nursing Staff, Hospital , Patient Transfer/economics , Patient Transfer/organization & administration , Patient Transfer/statistics & numerical data , Practice Guidelines as Topic , Prospective Studies , Registries , Survival Analysis , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...